1. Spironolactone not found to increase breast cancer risk

   Epidemiology population study 17 January 2013 Pages: 1 - 1

2. Antidiabetics linked to macular oedema, bladder cancer

   Epidemiology clinical study 17 January 2013 Pages: 2 - 2

3. Abuse-deterrent OxyContin: shift in abuse drug of choice

   Correspondence 17 January 2013 Pages: 2 - 2

4. PPI interaction with clopidogrel “clinically unimportant“

   News item 17 January 2013 Pages: 3 - 3

5. Benefits of influenza A H1N1 vaccination outweigh risks

   News item 17 January 2013 Pages: 3 - 3

6. HZ vaccine contraindication for immunosuppressants questioned

   Clinical study 17 January 2013 Pages: 4 - 4

7. GlaxoSmithKline, in consultation with Health Canada, has issued a letter to healthcare professionals regarding ambrisentan [Volibris].

   Correspondence 17 January 2013 Pages: 4 - 4

8. Rofecoxib CV risks: earlier confirmation was possible

   Incidence study 17 January 2013 Pages: 4 - 4

9. The EMA has announced that its proposed changes to product information for medicines are open for public consultation.

   Media release 17 January 2013 Pages: 4 - 4

10. The manufacture of BCG Immunotherapeutic [ImmuCyst] will temporarily cease, says Sanofi Pasteur,

    Media release 17 January 2013 Pages: 4 - 4

11. Alendronic acid/pamidronic acid

    Case report 17 January 2013 Pages: 5 - 5

12. Aldesleukin

    Case report 17 January 2013 Pages: 5 - 5

13. Acetazolamide

    Case report 17 January 2013 Pages: 5 - 5

14. Alprazolam

    Case report 17 January 2013 Pages: 5 - 6

15. Amikacin/cefotaxime/vancomycin

    Case report 17 January 2013 Pages: 6 - 6

16. Amiodarone

    Case report 17 January 2013 Pages: 6 - 6

17. Amitriptyline overdose

    Case report 17 January 2013 Pages: 6 - 6

18. Amlodipine

    Case report 17 January 2013 Pages: 7 - 7

19. Amphotericin B

    Case report 17 January 2013 Pages: 7 - 7

20. Antibacterials/fluconazole/immunosuppressants

    Case report 17 January 2013 Pages: 7 - 7

21. Antibacterials/prednisolone

    Case report 17 January 2013 Pages: 7 - 8

22. Antineoplastics

    Case report 17 January 2013 Pages: 8 - 8

23. Antineoplastics

    Case report 17 January 2013 Pages: 8 - 8

24. Aripiprazole/clozapine interaction

    Case report 17 January 2013 Pages: 9 - 9

25. Atorvastatin/warfarin interaction

    Case report 17 January 2013 Pages: 9 - 9

26. Aripiprazole

    Case report 17 January 2013 Pages: 9 - 9

27. Antineoplastics

    Case report 17 January 2013 Pages: 9 - 9

28. Arsenic trioxide

    Case report 17 January 2013 Pages: 9 - 9

29. Azathioprine

    Case report 17 January 2013 Pages: 10 - 10

30. BCG vaccine

    Case report 17 January 2013 Pages: 10 - 10

31. Betamethasone

    Case report 17 January 2013 Pages: 10 - 10

32. BCG

    Case report 17 January 2013 Pages: 10 - 10

33. Bevacizumab

    Case report 17 January 2013 Pages: 11 - 11

34. Betamethasone valerate/clobetasol

    Case report 17 January 2013 Pages: 11 - 11

35. Bevacizumab

    Case report 17 January 2013 Pages: 11 - 11

36. Bevacizumab/dexamethasone

    Case report 17 January 2013 Pages: 11 - 12

37. Bimatoprost

    Case report 17 January 2013 Pages: 12 - 12

38. Capsaicin

    Case report 17 January 2013 Pages: 12 - 12

39. Bortezomib

    Case report 17 January 2013 Pages: 12 - 12

40. Bortezomib

    Case report 17 January 2013 Pages: 12 - 12

41. Carbocisteine

    Case report 17 January 2013 Pages: 13 - 13

42. Carbamazepine/valproate

    Case report 17 January 2013 Pages: 13 - 13

43. Carbamazepine

    Case report 17 January 2013 Pages: 13 - 13

44. Carboplatin

    Case report 17 January 2013 Pages: 13 - 14

45. Celecoxib

    Case report 17 January 2013 Pages: 14 - 14

46. Carboplatin

    Case report 17 January 2013 Pages: 14 - 14

47. Carboplatin/paclitaxel

    Case report 17 January 2013 Pages: 14 - 14

48. Ciclosporin/prednisone/voriconazole

    Case report 17 January 2013 Pages: 15 - 15

49. Chlorpromazine

    Case report 17 January 2013 Pages: 15 - 15

50. Chloroquine

    Case report 17 January 2013 Pages: 15 - 15